Nirmish Shah

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 294 citations · Full text

Pulmonary Embolism, Thrombosis, Venous Thrombosis +9

Sickle cell disease complications: Prevalence and resource utilization

Nirmish Shah, Menaka Bhor, Lin Xie et al. · PLoS ONE · 2019 · 95 citations · Full text

Patients Welcome the Sickle Cell Disease Mobile Application to Record Symptoms<i>via</i>Technology (SMART)

Nirmish Shah, Jude Jonassaint, Laura M. De Castro · Hemoglobin · 2014 · 86 citations

Remote Patient Monitoring, Ehr Systems, Diagnosis +22

Usability and Feasibility of an mHealth Intervention for Monitoring and Managing Pain Symptoms in Sickle Cell Disease: The Sickle Cell Disease Mobile Application to Record Symptoms<i>via</i>Technology (SMART)

Charles R. Jonassaint, Nirmish Shah, Jude Jonassaint et al. · Hemoglobin · 2015 · 78 citations

Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: The emergency department providers’ perspective

Rita Masese, Dominique Bulgin, Christian Douglas et al. · PLoS ONE · 2019 · 74 citations · Full text